EHP Funds Inc’s Nuvation Bio NUVB Stock Holding History

EHP Funds Inc’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25,173	Closed	-$93.1K	–	72
2025 Q3	$93.1K	Buy	+25,173	New	+$68.6K	0.08%	91

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

EHP Funds Inc's NUVB Position: Q4 2025 in Review

EHP Funds Inc sold out of Nuvation Bio (NUVB) in Q4 2025, closing a stake of 25,173 shares — an estimated $93.1K sold.

EHP Funds Inc first reported a position in NUVB in Q3 2025 and held it in 1 quarter. The position peaked at $93.1K in Q3 2025. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

EHP Funds Inc reported no remaining Nuvation Bio position as of Q4 2025 after selling out during the quarter.
EHP Funds Inc sold 25,173 Nuvation Bio shares in Q4 2025, an estimated $93.1K.
EHP Funds Inc first reported a position in Nuvation Bio in Q3 2025 and held it in 1 quarter.
EHP Funds Inc's Nuvation Bio position peaked at $93.1K in Q3 2025.
223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on EHP Funds Inc's 13F filing for Q4 2025, filed 12 Feb 2026.